Tradipitant

曲地匹坦

Report date: 2026/04/21 20:00:18
NME

Base Information

Drug NameTradipitant
Drug Alias NameTradipitantumNereusVLY-686LY-686017NY0COC-51FI
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeurokinin 1 receptor antagonists
TargetsNeurokinin 1 receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Diabetic GastroparesisPhobia, Social +[11
Global Approved IndicationsVomitingMotion Sickness
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2025/12/30
Country/TerritoryBelgiumUnited StatesGermany +[4
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active IndicationsCoronavirus Disease 2019 (COVID-19)Diabetic GastroparesisVomiting +[7
Inactive IndicationsPhobia, SocialAlcoholismPruritus +[4

Other Information

ATC CodeN/A